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Shoulder pain is common, with a 1-year prevalence ranging between 5% and 47% (1-7). In occupational settings, the 1-year prevalence ranges between 16% and 47% (3) (4) (5) . A Finnish study (8) reported a 1-year incidence of 14% for shoulder pain among forestry workers. Shoulder pain has an unfavorable outcome in many patients. About 40% to 50% of all patients who go for a consultation in primary care due to a new episode of shoulder pain report persistent pain and disability after 6 to 12 months (9-11).
The early identification (risk stratification) of patients with a high risk of sick leave due to shoulder pain may enable timely intervention and prevent sick leave and the concomitant high costs these patients generate. We developed a clinical prediction rule consisting of the following four easily measurable prognostic factors: sick leave at baseline in the preceding 2 months (0/0-1/≥1 weeks), shoulder pain (0-10), strain or overuse due to usual activities as a precipitating cause (yes, no), and concomitant psychological complaints (yes, no) (table 1). Points are given for each of the four prognostic factors, and a total score is calculated.
The total score corresponds with the estimated risk for sick leave due to shoulder pain during the 6 months following a first consultation for patients with a new episode of shoulder pain in primary care. The performance Kuijpers et al (ie, calibration and discrimination) of the prediction rule was evaluated in the development study (12) . Calibration refers to the extent to which the observed frequencies agree with the predicted probabilities of sick leave. Discrimination refers to the ability to distinguish between a patient with a high risk for sick leave and a patient who will not have to stay off work because of shoulder pain.
Before the implementation of the prediction rule in clinical practice was considered, its generalizability needed to be tested (13) (14) (15) . Generalizability refers to the performance of patients drawn from a different but comparable population (13) . Our objective was to evaluate the performance of our clinical prediction rule for sick leave due to shoulder pain in two different cohorts of patients with shoulder pain in a primary care setting.
Study population and methods
In this study, we evaluated the generalizability of the derived prediction rule from a Dutch shoulder study in a subgroup of other patients from this cohort and among participants of another prospective cohort study in general practice, the musculoskeletal disorder study (MDS).
Dutch shoulder study
The Dutch shoulder study (DSS) was a comprehensive cohort study carried out between January 2000 and May 2005. It consisted of one prognostic cohort study and three randomized controlled trials, which were carried out in parallel (see figure 1 ). Between January 2001 and June 2003, 103 general practitioners recruited patients at their first consultation for a new episode of shoulder complaints in three geographic areas in the Netherlands (Amsterdam, Groningen, and Maastricht).
All of the patients in the Dutch shoulder study had to meet the following general inclusion criteria: was 18 years of age or older; had paid work; had not consulted a general practitioner or received any form of treatment for the afflicted shoulder in the preceding 3 months; and had sufficient knowledge of the Dutch language.
The patients had to meet the specific additional inclusion criteria of the trial in which they were included, if eligible, as follows: dysfunction of the cervicothoracic spine and adjacent ribs with accompanying pain or restricted movement in the Groningen manipulation study, >3-month duration of symptoms in the graded exercise therapy study, and <3-month duration of symptoms in the education and activation program.
In both the Dutch shoulder study and the musculoskeletal disorder study, those with severe physical or psychological conditions (ie, fractures or dislocation in the shoulder region, rheumatic disease, neoplasm, neurological or vascular disorders, dementia) were excluded. For the prognostic cohort study, no additional inclusion criteria were specified. Data from the prognostic cohort study were used to derive the prediction rule. Data from the control groups of the three trials were used to study the generalizability of the rule. For the current study only the patients who reported paid work were used.
The Groningen manipulation study (16) (17) evaluated the effectiveness of manipulative therapy for the shoulder girdle in addition to usual care. In the two other trials, graded exercise therapy (18) and an education and activation program (19) were used. The participants Prediction rule for sick leave related to shoulder pain were evenly allocated to the treatment groups on the basis of a random list prepared by an independent statistician not involved in recruiting the patients. A research assistant opened preprepared, numbered, opaque envelopes, which were sealed and contained the treatment allocation codes (16) (17) (18) (19) . The patients in the control groups of the trials received usual care, similar to that of the patients in the cohort study. Baseline and follow-up assessments for all of the patients were identical in the Dutch shoulder study. The outcome was measured with the use of postal questionnaires at 6 weeks, 3 months, and 6 months.
Musculoskeletal disorder study
The musculoskeletal disorder study (MDS) is a large observational cohort study that was conducted in 61 general practices (97 general practitioners) (20) (21) . The physicians recruited patients who consulted them due to a new episode of musculoskeletal pain. For our generalizability study, we selected patients who came for a consultation for shoulder pain and who had paid work at baseline. The selection criteria were comparable with those of the Dutch shoulder study. Follow-up questionnaires were sent after 3, 6, and 12 months.
Prediction rule
The rule predicted sick leave due to shoulder pain (yes = ≥1 day, no = 0 days) during 6 months after the first consultation with a physician about shoulder pain and was developed using information from the 350 patients of the derivation cohort who reported paid work at baseline. Sociodemographic variables, disease characteristics (ie, pain intensity, disability, duration of complaints, sick leave in the 2 months prior to the consultation, onset, comorbidity), physical workload, work-related psychosocial factors, psychological factors, and results of a physical examination were documented. The questionnaire also included a general single-item question regarding the presence (yes, no) of any psychological problems (eg, distress, depression, anxiety). These factors were used to compose a prognostic model and derive the prediction rule. We tested the internal validity with bootstrapping techniques and corrected the prediction rule for overoptimism (13) . The calibration of the prediction rule was adequate. The discriminative ability was satisfactory with an area under the receiver operating characteristic (ROC) curve of 0.70 [95% confidence interval (95% CI) 0.64-0.76]. In table 1 on page 441 the prediction rule is presented as a score chart. The Kuijpers et al development of this score chart and prediction rule has been described in detail elsewhere (12) .
Analysis
The performance of the prediction rule was tested in the validation cohorts by evaluating its calibration and discrimination. Calibration was assessed by plotting the predicted probabilities of sick leave according to the prediction rule, against the observed frequencies. For this process, the patients were grouped into quintiles according to their predicted probability of sick leave. The prevalence of the end point within each quintile equaled the observed frequency.
The area under the ROC curve was used to assess the discriminative ability of the prediction rule. An area under the curve (AUC) of 0.5 indicated no discrimination above chance, whereas an AUC of 1.0 indicated perfect discrimination. Since the discriminative ability of a rule is related to the homogeneity of the sample in which the rule is applied, we also estimated the maximum AUC attainable for the validation cohorts. With the use of the predicted risks of the patients in the validation cohorts, outcomes were generated with Monte Carlo simulation (22) (23) . The simulation mimics a situation in which the model is perfectly calibrated, thereby showing the extent to which poor calibration can affect the discriminative performance of the model. The AUC that is subsequently estimated for the predicted risks and generated outcomes is considered the maximum attainable AUC for the validation sample.
Furthermore, to gain insight into the performance of our prediction rule, we estimated the multivariable logistic regression coefficients for each of the predictors of our prediction rule in the validation cohorts. This analysis showed which of the different elements of the rule were the strongest predictors of sick leave in the validation cohorts. Table 2 presents the baseline characteristics of the derivation cohort and validation cohorts. The patients in the DSS control groups clearly showed a longer duration of complaints at baseline (>3 months: 51% versus 38%) and reported 10% more concomitant low-back pain in comparison with the derivation cohort. Patients in the musculoskeletal disorder study were less often male (42% versus 55%), more often reported strain or overuse due to usual activities as a precipitating cause (46% versus 28%), and more often reported concomitant musculoskeletal complaints of the neck or high back (58% versus 34%) and low back (34% versus 17%). The patients in the derivation and validation cohorts reported similar percentages of sick leave for the first 6 months after the first consultation (30% for the DSS derivation cohort, 34% for the DSS control groups, and 32% for the MDS cohort).
Results

Study population
In the MDS cohort, 90% of all of the patients completed the 6-month questionnaire. There were no significant differences between the respondents and dropouts with respect to gender, functional disability, or pain, although the dropouts were slightly younger. For the DSS controls, the dropout rate at 6 months was <10%. No information was available in regard to the differences between the respondents and the dropouts. Figure 2 shows the calibration of the predictions. For the DSS control groups the predicted risks for sick leave were generally too high. Nevertheless, the mean predicted probability of 0.37 was only slightly higher than the overall observed sick leave prevalence (0.32). For the MDS cohort most of the plotted points were rather close to the 45-degree line, although three prediction categories slightly overestimated the observed probabilities. Again, the mean predicted probability (0.39) was only slightly higher than the overall observed sick leave prevalence (0.34). The discriminative ability (AUC) of the prediction rule was 0.66 (95% CI 0.56-0.77) for the DSS controls groups and 0.71 (95% CI 0.63-0.80) for the MDS cohort. The results of the Monte Carlo simulation show that these estimates were close to the maximum attainable AUC (0.66 for the DSS controls and 0.70 for the MDS population), indicating that reductions in discrimination were not explained by poor calibration. Table 3 shows the multivariate regression coefficients when the rule was applied to the validation cohorts. Shoulder pain was a strong predictor of sick leave in the DSS control groups and in the MDS cohort. In the MDS cohort, sick leave in the 2 months preceding the baseline examination also showed a strong relation to sick leave during the follow-up. The category "0-1 weeks" showed a remarkable negative association with outcome among the DSS controls. A similar opposite association was found for the category "4-6 points, shoulder pain" in the MDS cohort.
Performance
Discussion
The performance of the prediction rule for sick leave due to shoulder pain in the DSS control groups showed an unstable calibration and a slightly decreased discriminative ability (AUC of 0.66, compared with an AUC of 0.70 in the derivation cohort). The prediction rule calibrated better for the MDS population and showed a stable discriminative ability (AUC 0.71).
The validation of a prediction rule is preferably started with populations that are very similar to the derivation cohort. In the next step, the rule is tested in populations that show more differences from the Figure 2 . Calibration plots showing the observed frequencies versus the predicted probabilities for sick leave due to shoulder pain during the 6 months following the first consultation in primary care, for the controls of the Dutch shoulder study (DSS) (N=103) and a cohort of the musculoskeletal disorder study (MDS) (N=176). The patients were grouped into quintiles according to their predicted probability of sick leave due to shoulder pain according to the prediction rules. The prevalence of the end point within each quintile represents the observed individual probability.
Figure 2
Calibration plots showing the observed frequencies versus the predicted probabilities for shoulder pain related sick leave during 6 months following first consultation in primary care, for the DSS-controls (n=103) and the BAS cohort (n=176). Patients were grouped into quintiles according to their predicted probability of shoulder pain related sick leave according to the prediction rules. The prevalence of the endpoint within each quintiles represents the observed individual probability. 
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Kuijpers et al derivation cohort in terms of, for example, baseline characteristics or setting (13) . The DSS was designed specifically to design and validate a clinical prediction rule for shoulder pain. The patients in both the derivation and validation cohorts (DSS control groups) were recruited by the same group of general practitioners, and they received similar treatment. The measurements were exactly the same and were carried out by the same research teams. This was an optimal setting in which to start testing the generalizability of the prediction rule. Although there was considerable similarity in the sampling frame and data collection between the DSS controls and the MDS participants, a different group of general practitioners participated in the MDS, the treatment may have been somewhat different, and the data collection showed some differences. The MDS cohort was therefore a good cohort for use in the second step of the validation process. At the time of our study, no other good cohorts were available.
Patients that originate from clinical trials usually form a more selective population than patients participating in observational studies. Although the trials in the DSS used fairly broad selection criteria, this difference may have influenced the performances of the prediction rule with respect to the DSS controls. For example, the DSS controls included more patients with a long symptom duration, which is an important prognostic factor. In addition, it may be possible that the patients who participated in the trials had different characteristics that were not measured in our study, for example, regarding treatment expectations or preferences.
Finally, the unstable calibration with the DSS control groups may also have partly been a result of the small numbers (N=103) in this validation cohort. Other studies have also shown that the calibration of prediction rules can be unstable when applied to a small population (24) . Table 3 shows large differences between the regression coefficients in the derivation cohort and the DSS controls. Shoulder pain was the only predictor among the DSS controls with a large and significant regression coefficient. The decreased AUC of 0.66 was confirmed by an equal maximum attainable AUC. This decreased discriminative ability may have been a result of differences in the baseline characteristics between the derivation and this validation cohort.
In the MDS cohort, shoulder pain and sick leave at baseline in the preceding 2 months showed substantial and significant regression coefficients (table 3) . This phenomenon, combined with higher regression coefficients for strain or overuse due to usual activities and concomitant psychological complaints in the MDS cohort in comparison with the DSS controls, may have resulted in a better performance of the prediction rule for the MDS cohort. The substantial baseline differences between the derivation cohort and the MDS, in regard to factors that were not included in the prediction rule (gender, strain or overuse due to unusual activities, and concomitant musculoskeletal pain), did not seem to alter the performance. The maximum attainable AUC of 0.70 in the MDS cohort strengthens our findings of adequate discriminative ability in this cohort.
We developed a rule to predict sick leave due to shoulder pain during the first 6 months after a first consultation. The elements of the prediction rule were derived from a questionnaire filled out by the patient. If the prediction rule is used in daily practice, it is the physician who will ask the questions and calculate the risk by using a score chart, or, in a more sophisticated way, enters the responses into a personal computer (PC) or personal digital assistant (PDA), which calculates the risk of sick leave over the next six months. Therefore, future research should also evaluate the methodological transportability of the prediction rule [ie, performance when data are collected with alternative methods (13) in a new sample of workers], and, perhaps most importantly, the clinical usefulness of the instrument should be established. In other words, can the prediction rule be helpful in making decisions in the management of patients with shoulder pain, for example, whether or not to consider additional diagnostic testing, start a certain treatment, or refer the patient to secondary care (15)? Table 3 . Multivariate regression coefficients for sick leave due to shoulder pain during 6 months after the first consultation in the validation in comparison with the coefficients obtained from the derivation cohort. The b values were derived from a multiple logistic regression analysis and were shrunk using bootstrapping techniques. The b values for the validation cohorts were computed by entering the four predictors of the rule simultaneously into a multiple logistic regression analysis, demonstrating the strength of the association between the predictors and sick leave in the validation cohorts in comparison with the derivation cohort. (DSS = Dutch shoulder study, MDS = musculoskeletal disorder study, b= regression coefficient, 95% CI = 95% confidence interval) In conclusion, the prediction rule for sick leave due to shoulder pain during the first 6 months after a first consultation showed disappointing generalizability for the DSS controls but adequate generalizability for the MDS observational cohort.
To enhance the performance of prediction rules in the future, rules should be updated and amended when new and larger cohorts become available. Validation should preferably be carried out prospectively, and-when sick leave is being predicted-in an occupational setting. Alternatively, separate models can be designed for patients with either acute or chronic shoulder problems, as different factors may be important in predicting outcome in these different patient groups. This step may further enhance the predictive performance of prediction rules for shoulder pain.
